341: NIH funding cuts, a U.S. brain drain, and bold claims from AI drug developers
The Readout Loud
NIH Funding Cuts and Their Aftermath
This chapter explores the recent NIH funding cuts and their significant impact on biomedical innovation and the biopharma industry in the U.S. It details the legal responses from academic institutions and the potential financial repercussions of reduced support for overhead costs essential to research operations.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
